Category: PMCPA Case of the Week

Cases selected for the AskAnzal weekly PMCPA insight newsletter

8 Mar 2026

AUTH/3057/8/18: CCG employee v Novo Nordisk (Victoza) β€” no breach over alleged handwritten eGFR claim

CCG alleged a Novo Nordisk rep asked a receptionist to add a handwritten Victoza claim about use at…

8 Mar 2026

GSK Duac banner ad on Pulse Today: complaint about missing prescribing information (AUTH/3367/7/20) – No breach

A UK health professional said a Duac 5% Pulse Today banner was static and lacked prescribing info. GSK…

8 Mar 2026

Daiichi-Sankyo: sponsorship disclosure in third-party YouTube meeting recording (Lixiana) found unclear from the outset

A patient complained about a YouTube-hosted meeting recording mentioning Lixiana. Most allegations were not upheld, but Daiichi-Sankyo was…

8 Mar 2026

Daiichi-Sankyo: draft corporate webpage accidentally went live and promoted POMs to the public (breach of undertaking)

A draft β€œfooter content” webpage became searchable on Daiichi-Sankyo’s UK site and promoted olmesartan, prasugrel and edoxaban to…

8 Mar 2026

Chiesi breached the ABPI Code after a third-party event email implied sponsorship of a prize draw tied to attending its promotional session (AUTH/3621/3/22)

A MIMS Live event reminder offered a prize draw requiring attendance across all days, including Chiesi’s promotional session.…

8 Mar 2026

Sobi sponsored Guardian haemophilia article: no breach (AUTH/3696/10/22)

Anonymous complaint alleged a Guardian-sponsored corporate article was disguised promotion and misleading. PMCPA Panel ruled no breach of…

8 Mar 2026

Novo Nordisk: sponsorship of pharmacy weight-loss services, free consumables and missing Disclosure UK entry (Saxenda) | AUTH/3821/9/23

PMCPA found Novo Nordisk breached Clauses 2, 5.1/9.1 and 28.1 over pharmacy-chain sponsorships that weren’t truly arm’s length,…

8 Mar 2026

Roche: AMD audit reportsβ€”patient summary lacked funding disclosure; grant agreement wording also fell short (AUTH/3851/11/23)

PMCPA found Roche breached Clause 5.5 because a patient summary of an AMD audit report did not disclose…

8 Mar 2026

Teva UK Ltd: Guidelines in Practice insert on switching to CFC-free beclometasone inhalers (Qvar) found misleading and promotional

A GP challenged a Teva-supported insert distributed with Guidelines in Practice. The Panel found it was effectively a…

8 Mar 2026

AUTH/2208/2/09: Health professional v Gilead Sciences – unsolicited email about fellowship programme (no breach)

A health professional complained about an unsolicited email advertising a Gilead fellowship programme. The Panel found the email…

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training